Profile data is unavailable for this security.
About the company
Linical Co., Ltd. is a Japan-based company mainly engaged in the contract research organization (CRO) business for drug companies. The Company operates in two businesses. The CRO segment is engaged in the provision of contract monitoring, quality management and consulting services for phase II and phase III in drug development processes. The Pharmaceutical Sales Support segment is engaged in provision of pharmaceutical sales support for medical institutions in the downstream market.
- Revenue in JPY (TTM)12.52bn
- Net income in JPY680.40m
- Incorporated2005
- Employees759.00
- LocationLinical Co Ltd10F, Shin-Osaka Brick Bldg1-6-1, MiyaharaYodogawa-kuOSAKA-SHI 532-0003JapanJPN
- Phone+81 661502478
- Fax+81 661502675
- Websitehttps://www.linical.co.jp/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chiome Bioscience Inc | 682.46m | -1.22bn | 7.19bn | 51.00 | -- | 5.86 | -- | 10.53 | -24.67 | -24.67 | 13.77 | 22.00 | 0.3441 | 4.19 | 6.88 | 13,381,650.00 | -61.51 | -50.50 | -79.81 | -57.38 | 58.41 | 57.53 | -178.77 | -224.74 | 2.90 | -513.93 | 0.2009 | -- | 8.19 | 26.24 | 1.84 | -- | -- | -- |
| Carna Biosciences, Inc. | 1.63bn | -1.15bn | 7.98bn | 67.00 | -- | 2.06 | -- | 4.91 | -69.84 | -69.84 | 96.78 | 226.16 | 0.3774 | 1.36 | 3.35 | 24,267,000.00 | -26.76 | -14.45 | -29.55 | -16.95 | 89.22 | 90.59 | -70.91 | -35.42 | 10.78 | -312.97 | 0.0451 | -- | 17.24 | 16.59 | 14.57 | -- | -27.69 | -- |
| Wakamoto Pharmaceutical Co Ltd | 7.98bn | -177.67m | 8.08bn | 292.00 | -- | 0.6881 | 34.75 | 1.01 | -5.12 | -5.12 | 229.89 | 337.15 | 0.525 | 2.08 | 2.88 | 27,324,600.00 | -1.17 | -2.58 | -1.34 | -3.00 | 46.98 | 53.08 | -2.23 | -4.33 | 3.45 | -- | 0.0085 | -- | 3.31 | -4.50 | -42.04 | 1.88 | -17.49 | 0.00 |
| Symbio Pharmaceuticals Ltd | 5.59bn | -1.96bn | 8.22bn | 109.00 | -- | 1.05 | -- | 1.47 | -48.74 | -48.74 | 139.70 | 170.89 | 0.6009 | 3.36 | 3.73 | 51,281,720.00 | -21.10 | -19.18 | -24.97 | -23.62 | 78.91 | 65.84 | -35.11 | -24.32 | 8.21 | -- | 0.00 | -- | -44.15 | 7.82 | -266.45 | -- | 42.39 | -- |
| CanBas Co Ltd (Parent) | 0.00 | -1.07bn | 8.33bn | 12.00 | -- | 2.64 | -- | -- | -64.96 | -64.96 | 0.00 | 174.81 | 0.00 | -- | -- | 0.00 | -40.62 | -65.86 | -42.95 | -79.11 | -- | -- | -- | -1,094.10 | -- | -- | 0.00 | -- | -- | -- | -45.41 | -- | -- | -- |
| Stella Pharma Corp | 254.09m | -765.17m | 8.65bn | 46.00 | -- | 3.24 | -- | 34.04 | -25.23 | -25.23 | 8.32 | 85.55 | 0.0637 | 0.0456 | 3.58 | 5,523,718.00 | -19.18 | -- | -20.37 | -- | 82.76 | -- | -301.14 | -- | 11.90 | -1,173.12 | 0.2671 | -- | 128.85 | -- | -1.45 | -- | -- | -- |
| Tsubota Laboratory Inc | 246.60m | -1.07bn | 9.21bn | 10.00 | -- | 8.74 | -- | 37.34 | -42.31 | -42.31 | 9.94 | 41.17 | 0.1023 | 2.20 | 29.16 | 24,660,200.00 | -44.25 | -- | -64.34 | -- | -182.07 | -- | -432.63 | -- | 1.92 | -417.04 | 0.1046 | -- | 48.96 | -- | -41.18 | -- | -- | -- |
| TMS Co Ltd | 0.00 | -960.04m | 9.35bn | 14.00 | -- | 2.70 | -- | -- | -25.89 | -25.89 | 0.00 | 85.77 | 0.00 | -- | -- | -- | -26.14 | -- | -26.78 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -11.51 | -- | -- | -- |
| 3-D Matrix Ltd | 3.74bn | -1.06bn | 9.36bn | 108.00 | -- | 15.24 | -- | 2.50 | -14.90 | -14.90 | 54.06 | 7.74 | 0.6653 | 0.4654 | 5.19 | 34,630,130.00 | -18.91 | -57.69 | -23.28 | -77.31 | 64.04 | 40.76 | -28.43 | -205.34 | 2.33 | -- | 0.8717 | -- | 53.63 | 58.87 | -29.09 | -- | -7.69 | -- |
| Linical Co Ltd | 12.52bn | 680.40m | 9.80bn | 759.00 | 13.15 | 1.14 | 8.24 | 0.7826 | 30.12 | 30.12 | 554.28 | 346.38 | 0.7251 | -- | 3.99 | 16,494,230.00 | 3.94 | 4.71 | 6.55 | 7.23 | 33.10 | 31.60 | 5.43 | 5.98 | -- | 17,809.03 | 0.2793 | 45.36 | 8.32 | 6.55 | 27.06 | -4.97 | -33.01 | 4.94 |
| Veritas In Silico Inc | 360.36m | 33.05m | 10.83bn | 15.00 | 318.42 | 6.68 | 180.59 | 30.06 | 5.24 | 5.24 | 57.19 | 250.05 | -- | -- | -- | 24,023,730.00 | -- | -- | -- | -- | -- | -- | 9.17 | -- | 20.19 | -- | 0.00 | -- | 101.54 | -- | 123.38 | -- | -- | -- |
| AnGes Inc | 152.99m | -7.44bn | 10.88bn | 145.00 | -- | 0.3802 | -- | 71.14 | -39.40 | -39.40 | 0.8083 | 131.52 | 0.0045 | 0.1037 | 8.40 | 1,055,069.00 | -21.97 | -28.50 | -25.69 | -33.14 | 12.71 | 39.42 | -4,861.66 | -6,726.82 | 1.75 | -- | 0.0137 | -- | 128.13 | -24.17 | 49.45 | -- | 12.11 | -- |
| KOEI CHEMICAL COMPANY, LIMITED | 18.49bn | 62.58m | 11.02bn | 387.00 | 175.70 | 0.5065 | 3.75 | 0.5958 | 12.79 | 12.79 | 3,779.78 | 4,437.99 | 0.4599 | 1.30 | 4.51 | 47,770,930.00 | 0.1557 | 3.76 | 0.206 | 4.68 | 24.91 | 24.12 | 0.3385 | 6.66 | 0.5356 | 1.77 | 0.3089 | 35.80 | 7.55 | 0.4997 | -26.56 | -33.82 | 15.68 | 20.11 |
| Medinet Co Ltd | 724.63m | -1.41bn | 11.78bn | 98.00 | -- | 2.01 | -- | 16.26 | -6.31 | -6.31 | 3.23 | 22.88 | 0.1224 | 11.93 | 3.61 | 7,394,143.00 | -23.74 | -21.05 | -24.75 | -22.47 | 17.72 | 28.75 | -193.90 | -135.40 | 19.58 | -- | 0.00 | -- | 4.40 | -7.90 | -14.66 | -- | -17.67 | -- |
| ReproCell Inc | 2.51bn | -217.49m | 12.37bn | 92.00 | -- | 1.53 | -- | 4.94 | -2.56 | -2.56 | 29.48 | 90.90 | 0.3008 | 4.86 | 7.44 | 27,247,390.00 | -2.61 | -9.37 | -2.80 | -10.11 | 43.55 | 38.78 | -8.68 | -38.12 | 11.94 | -- | 0.00 | -- | 32.16 | 26.10 | 46.91 | -- | 28.24 | -- |
Data as of Apr 23 2024. Currency figures normalised to Linical Co Ltd's reporting currency: Japanese Yen JPY
7.05%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Seven Canyons Advisors LLCas of 31 Dec 2023 | 743.30k | 3.00% |
| Sawakami Asset Management, Inc.as of 31 Jan 2024 | 348.70k | 1.41% |
| Nomura Asset Management Co., Ltd.as of 29 Mar 2024 | 186.50k | 0.75% |
| Dimensional Fund Advisors LPas of 04 Apr 2024 | 115.10k | 0.47% |
| Nikko Asset Management Co., Ltd.as of 05 Apr 2024 | 86.30k | 0.35% |
| Daiwa Asset Management Co. Ltd.as of 29 Mar 2024 | 83.20k | 0.34% |
| Norges Bank Investment Managementas of 31 Dec 2023 | 68.50k | 0.28% |
| The Vanguard Group, Inc.as of 31 Mar 2024 | 58.76k | 0.24% |
| Mitsubishi UFJ Asset Management Co., Ltd.as of 05 Apr 2024 | 36.80k | 0.15% |
| BlackRock Japan Co. Ltd.as of 04 Apr 2024 | 18.10k | 0.07% |
More ▼
Data from 31 Dec 2023 - 31 Mar 2024Source: FactSet Research Systems Inc.
